[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gulf Pharmaceutical Industries PSC (JULPHAR) - Financial and Strategic SWOT Analysis Review

November 2021 | 44 pages | ID: GFC68D4975CEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Gulf Pharmaceutical Industries PSC (JULPHAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa region. The company's product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primary care, pediatric primary care, gastro care, cardiopulmonary care and pain management and consumer care products. The company has manufacturing facilities in Ethiopia, Bangladesh and Saudi Arabia. Julphar has offices in Asia, Middle East and Africa and is headquartered in Digdaga, Ras Al Khaimah, the UAE.

Gulf Pharmaceutical Industries PSC Key Recent Developments

Aug 16,2020: Gulf Pharmaceutical Industries (Julphar) reports financial results for Q2 2020
Jun 09,2020: Julphar resumes sales of products in Bahrain and Kuwait
Apr 30,2020: Julphar resumes sales of products in KSA
Apr 05,2020: Julphar appoints new CEO to drive operational transformation and fuel growth
Mar 18,2020: Julphar relaunches over 80 products in Oman

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Gulf Pharmaceutical Industries PSC - Key Facts
Gulf Pharmaceutical Industries PSC - Key Employees
Gulf Pharmaceutical Industries PSC - Key Employee Biographies
Gulf Pharmaceutical Industries PSC - Major Products and Services
Gulf Pharmaceutical Industries PSC - History
Gulf Pharmaceutical Industries PSC - Company Statement
Gulf Pharmaceutical Industries PSC - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Gulf Pharmaceutical Industries PSC - Business Description
Business Segment: Manufacturing
Performance
Geographical Segment: Egypt
Performance
Geographical Segment: Others
Performance
Geographical Segment: Saudi Arabia
Performance
Geographical Segment: UAE
Performance
Gulf Pharmaceutical Industries PSC - SWOT Analysis
SWOT Analysis - Overview
Gulf Pharmaceutical Industries PSC - Strengths
Gulf Pharmaceutical Industries PSC - Weaknesses
Gulf Pharmaceutical Industries PSC - Opportunities
Gulf Pharmaceutical Industries PSC - Threats
Gulf Pharmaceutical Industries PSC - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Gulf Pharmaceutical Industries PSC, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 16, 2020: Gulf Pharmaceutical Industries (Julphar) reports financial results for Q2 2020
Jun 09, 2020: Julphar resumes sales of products in Bahrain and Kuwait
Apr 30, 2020: Julphar resumes sales of products in KSA
Apr 05, 2020: Julphar appoints new CEO to drive operational transformation and fuel growth
Mar 18, 2020: Julphar relaunches over 80 products in Oman

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Gulf Pharmaceutical Industries PSC, Key Facts
Gulf Pharmaceutical Industries PSC, Key Employees
Gulf Pharmaceutical Industries PSC, Key Employee Biographies
Gulf Pharmaceutical Industries PSC, Major Products and Services
Gulf Pharmaceutical Industries PSC, History
Gulf Pharmaceutical Industries PSC, Subsidiaries
Gulf Pharmaceutical Industries PSC, Key Competitors
Gulf Pharmaceutical Industries PSC, Ratios based on current share price
Gulf Pharmaceutical Industries PSC, Annual Ratios
Gulf Pharmaceutical Industries PSC, Annual Ratios (Cont...1)
Gulf Pharmaceutical Industries PSC, Annual Ratios (Cont...2)
Gulf Pharmaceutical Industries PSC, Interim Ratios
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Gulf Pharmaceutical Industries PSC, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Gulf Pharmaceutical Industries PSC, Performance Chart (2016 - 2020)
Gulf Pharmaceutical Industries PSC, Ratio Charts
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications